These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9337764

  • 1. Melatonin.
    Cupp MJ.
    Am Fam Physician; 1997 Oct 01; 56(5):1421-5, 1428. PubMed ID: 9337764
    [Abstract] [Full Text] [Related]

  • 2. Melatonin for primary insomnia?
    Drug Ther Bull; 2009 Jul 01; 47(7):74-7. PubMed ID: 19567841
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2007 Oct 01; 23(10):2597-605. PubMed ID: 17875243
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia.
    Hoebert M, van der Heijden KB, van Geijlswijk IM, Smits MG.
    J Pineal Res; 2009 Aug 01; 47(1):1-7. PubMed ID: 19486273
    [Abstract] [Full Text] [Related]

  • 9. Clinical aspects of melatonin.
    Reiter RJ, Korkmaz A.
    Saudi Med J; 2008 Nov 01; 29(11):1537-47. PubMed ID: 18997997
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
    Hardeland R.
    Curr Opin Investig Drugs; 2009 Jul 01; 10(7):691-701. PubMed ID: 19579175
    [Abstract] [Full Text] [Related]

  • 13. Complementary and alternative medicines patients are talking about: melatonin.
    Lee CO.
    Clin J Oncol Nurs; 2006 Feb 01; 10(1):105-7. PubMed ID: 16482735
    [Abstract] [Full Text] [Related]

  • 14. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
    Pandi-Perumal SR, Srinivasan V, Poeggeler B, Hardeland R, Cardinali DP.
    Nat Clin Pract Neurol; 2007 Apr 01; 3(4):221-8. PubMed ID: 17410109
    [Abstract] [Full Text] [Related]

  • 15. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P, Nir T, Laudon M, Zisapel N.
    J Sleep Res; 2007 Dec 01; 16(4):372-80. PubMed ID: 18036082
    [Abstract] [Full Text] [Related]

  • 16. Neurobiological effects of melatonin as related to cancer.
    Hoang BX, Shaw DG, Pham PT, Levine SA.
    Eur J Cancer Prev; 2007 Dec 01; 16(6):511-6. PubMed ID: 18090123
    [Abstract] [Full Text] [Related]

  • 17. Potential action of melatonin in insomnia.
    Rogers NL, Dinges DF, Kennaway DJ, Dawson D.
    Sleep; 2003 Dec 15; 26(8):1058-9. PubMed ID: 14746391
    [No Abstract] [Full Text] [Related]

  • 18. Ramelteon for the treatment of insomnia.
    Borja NL, Daniel KL.
    Clin Ther; 2006 Oct 15; 28(10):1540-55. PubMed ID: 17157111
    [Abstract] [Full Text] [Related]

  • 19. Management of chronic insomnia in elderly persons.
    Bain KT.
    Am J Geriatr Pharmacother; 2006 Jun 15; 4(2):168-92. PubMed ID: 16860264
    [Abstract] [Full Text] [Related]

  • 20. Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study.
    Braam W, Didden R, Smits M, Curfs L.
    J Intellect Disabil Res; 2008 Mar 15; 52(Pt 3):256-64. PubMed ID: 18261024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.